Raloxifene HCl, a selective estrogen receptor modulator (SERM), is primarily used for the prevention and treatment of osteoporosis in postmenopausal women. Its unique mechanism allows it to mimic estrogen’s beneficial effects on bone density while avoiding some of the adverse effects associated with traditional hormone replacement therapies.
For a detailed exploration of Raloxifene HCl and its effects, you can read more at https://pizza-alcapriccio-refrath.de/2026/05/24/understanding-the-effects-of-raloxifene-hcl/.



